Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Aimmune Accelerates Commercial Planning For Peanut Allergy Drug

Related Content

'Breakthrough' status granted to Aimmune's peanut allergy drug

Jun 19 2015

Aimmune Gets $145m From Nestlé To Advance Food Allergy Immunotherapies

Nov 04 2016

DBV Technologies Misses With Viaskin Peanut Allergy Patch

Oct 23 2017

Related Companies

Aimmune Therapeutics, Inc.

Nestle Health Science

DBV Technologies

Additional Topics

Clinical Trials Pediatrics Business Strategies Research & Development Immune Disorders BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window